![Richard Mountfield](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Richard Mountfield
Consejero General en AURA BIOSCIENCES, INC. .
Cargos activos de Richard Mountfield
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
AURA BIOSCIENCES, INC. | Consejero General | - | - |
Historial de carrera de Richard Mountfield
Antiguos cargos conocidos de Richard Mountfield.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Zenas Pharma, Inc.
![]() Zenas Pharma, Inc. BiotechnologyHealth Technology Zenas Pharma, Inc. is an American pharmaceutical company that is focused on developing a portfolio of first- and autoimmune therapeutics to address areas of high unmet medical need. The company is located in the US. The company's lead product candidate, obexelimab (zb012), is a novel bifunctional antibody with first-in-class potential that inhibits B-cell lineages that express CD19. | Consejero General | 01/10/2021 | 01/05/2023 |
CONSTELLATION PHARMACEUTICALS, INC. | Consejero General | 01/07/2020 | 01/10/2021 |
Boston Pharmaceuticals, Inc.
![]() Boston Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Boston Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that leverages a drug development team to advance a portfolio of high value candidates that address important unmet medical needs. The company was founded by Robert Armstrong and Chris Viehbacher and is headquartered in Cambridge, MA. | Consejero General | 01/10/2016 | 01/07/2020 |
CELYAD ONCOLOGY SA | Consejero General | 03/02/2016 | - |
Formación de Richard Mountfield.
University of Aberystwyth | Doctorate Degree |
Coventry University | Undergraduate Degree |
Estadísticas
Internacional
Estados Unidos | 5 |
Reino Unido | 3 |
Bélgica | 2 |
Operativa
General Counsel | 5 |
Doctorate Degree | 1 |
Undergraduate Degree | 1 |
Sectorial
Health Technology | 5 |
Consumer Services | 3 |
Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
CELYAD ONCOLOGY SA | Health Technology |
AURA BIOSCIENCES, INC. | Health Technology |
Empresas privadas | 3 |
---|---|
Constellation Pharmaceuticals, Inc.
![]() Constellation Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Constellation Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel therapeutics in the field of epigenetics. The firm utilizes epigenetics platform, which enables to validate targets and generate small molecules against these targets that selectively modulate gene expression in tumor and immune cells to drive anti-tumor activity. Its product include CPI-0610, CPI-1205, and CPI-0209. The company was founded by Danny Reinberg, David Allis, and Yang Shi on January 11, 2008 and is headquartered in Cambridge, MA. | Health Technology |
Boston Pharmaceuticals, Inc.
![]() Boston Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Boston Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that leverages a drug development team to advance a portfolio of high value candidates that address important unmet medical needs. The company was founded by Robert Armstrong and Chris Viehbacher and is headquartered in Cambridge, MA. | Commercial Services |
Zenas Pharma, Inc.
![]() Zenas Pharma, Inc. BiotechnologyHealth Technology Zenas Pharma, Inc. is an American pharmaceutical company that is focused on developing a portfolio of first- and autoimmune therapeutics to address areas of high unmet medical need. The company is located in the US. The company's lead product candidate, obexelimab (zb012), is a novel bifunctional antibody with first-in-class potential that inhibits B-cell lineages that express CD19. | Health Technology |
- Bolsa de valores
- Insiders
- Richard Mountfield
- Experiencia